MCL1 and neoplasm: Indeed, we found that MLN0128 treatment effectively suppressed c-MYC/MCL1/RictorKOTsc2KO tumor growth, and it was more effective than the p70S6K/RPS6 inhibitor everolimus (Figure 4).